Log in
Enquire now
‌

US Patent 11661426 Imidazole-containing inhibitors of ALK2 kinase

Patent 11661426 was granted and assigned to BioCryst Pharmaceuticals on May, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11661426 Imidazole-containing inhibitors of ALK2 kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo